article thumbnail

Key drug development trends and predictions for 2024

Drug Discovery World

Dr Julie Warner is Vice President of Regulatory Affairs at drug development consultancy, Boyds. In this article, she provides her expert insights into the key trends and developments expected to shape the global drug development industry this year.

article thumbnail

Webinar: Overcome the challenges of outsourcing in drug development

Drug Discovery World

Join DDW and Revvity Signals for this free event ‘ Enhancing collaboration between sponsors and contract partners in drug discovery ’. The post Webinar: Overcome the challenges of outsourcing in drug development appeared first on Drug Discovery World (DDW). Register for free now to secure your place.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

First spaceflight mission for drug development lab

Drug Discovery World

On the inaugural PIL-BOX-01 mission, Eli Lilly is partnering with Redwire to conduct three experiments focused on developing advanced treatments for diabetes, cardiovascular disease, and pain. The post First spaceflight mission for drug development lab appeared first on Drug Discovery World (DDW).

article thumbnail

Latest Guide: Streamline your drug development pathway

Drug Discovery World

In pharmaceutical development, collaborating with multiple Contract Development and Manufacturing Organisations (CDMOs) and Contract Research Organisations (CROs) poses potential hurdles – from poor communication to delays, errors, and inconsistent feedback during the progression from preclinical to formulation optimisation and clinical trials.

article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management.

article thumbnail

2023 cancer research highlights: Drug development at its best

Drug Discovery World

A Phase I clinical trial, sponsored and managed by Cancer Research UK’s Centre for Drug Development, tested whether a type of antibody called IgE could be used to treat cancer. The drug, MOv18 IgE (an anti-folate receptor alpha IgE antibody), was developed by researchers at King’s College London.

article thumbnail

Streamline your drug development pathway

Drug Discovery World

The post Streamline your drug development pathway appeared first on Drug Discovery World (DDW).